List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
GELATIN MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Food & Beverage | Published by: IMARC GROUP | Market: |
| 127 pages | Published: 2/11/2019 |
- Food & Beverage
- IMARC GROUP
- 127 pages
- Published: 2/11/2019
Gelatin is an animal protein which is obtained from the collagen found in the bones, connective tissue, and skin of pigs, cattle and other animals. The use of gelatin has advanced manifolds since its primary application as a biological adhesive in ancient times. Due to gelatin’s numerous physical, chemical and functional properties such as crystallization control, water binding, film forming, thickening and emulsifying properties, it finds diversified uses in a number of industries such as food, pharmaceutical, nutraceutical, photographic, cosmetic and packaging industries. Besides these, gelatin also finds its applications in combating osteoporosis and arthritis.
According to IMARC Group’s recently published report titled “Gelatin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global gelatin market is currently being driven by an increasing demand for functional and convenience foods, growth in end-user industries, rising health awareness and growth in emerging markets. Owing to these factors, this market has grown at a CAGR of around 8.1% during 2011-2018. The report further provides a comprehensive insight into the industry including its market break-up by region, market breakup by end-uses, value chain analysis, import and export trends, key players and market outlook. The report also gives an insight into the manufacturing process of gelatin covering key success and risk factors for manufacturers, manufacturing process flow, the reactions involved, raw materials and their requirements, etc.
The report has segmented the global gelatin market on the basis of end-use industries. The food and beverage sector currently represents the largest end-use sector followed by nutraceuticals, pharmaceuticals, photography, cosmetics and others. In the food and beverage sector, gelatin is widely used in bakeries and confectionaries, wine fining, meat products, etc. In the nutraceuticals sector, it is used in nutritional bars and protein drinks. In the pharmaceutical sector, it is used in making hard and soft capsules, stabilizers for oil emulsions, glycerinated gelatin for suppositories, etc. In the photography sector, gelatin is used in paper coating and as a component in silver halide emulsion coatings.
The report has also provided the market analysis based on key regions and finds that Europe currently represents the biggest producer of gelatin followed by North America, Asia, South America and others. Based on the global import and export data, the report finds that the United States is currently the largest importer of Gelatin and its derivatives followed by Germany, Belgium, Japan and United Kingdom. On the other hand, Brazil is the world’s largest exporter of Gelatin and its derivatives. Other major exporters include Germany, France, Belgium and United States. The report has also analysed the key players operating in the global gelatin market. At present, there are around 25-30 manufacturers of gelatin across the world, out of which, Gelita AG (Formerly DGF Stoess), Rousselot SAS, PB Gelatin (Tessenderlo Group), Sterling Biotech Ltd, Weishardt Group and Nitta Gelatin are the key manufacturers.
The essential aspects of the global gelatin market evaluated in the report include:
- Market trends
- Major regions
- Key application areas
- Key manufacturers
- Price trends
- Raw material requirements
- Chemical reactions involved in the manufacturing process
- Major importers and exporters
- Value chain analysis
- Market trends for major feedstocks
- Price trends for major feedstocks
- Key regions for major feedstocks
- Key application areas for major feedstocks
- Key players for major feedstocks
1. Preface |
Market by Raw Material
- Pig Skin
- Bovine Hides
- Bones
- Other Sources
Market by End-Use
- Food and Beverages
- Nutraceuticals
- Pharmaceuticals
- Photography
- Cosmetics
- Others
FRUIT JUICE MARKET: GLOBAL INDUSTRY TRENDS, SHARE, SIZE, GROWTH, OPPORTUNITY AND FORECAST 2019-2024
| Food & Beverage | Published by: IMARC GROUP | Market: |
| 127 pages | Published: 2/11/2019 |
- Food & Beverage
- IMARC GROUP
- 127 pages
- Published: 2/11/2019
The global fruit juice market reached a volume of 45.4 Billion Litres in 2018, registering a CAGR of around 2% during 2011-2018. The market is further projected to reach a volume of 50.6 Billion Litres by 2024. Fruit juice refers to a non-fermented beverage which is obtained by mechanically squeezing or macerating fruits. Different types of fruit juice offer varied health benefits, for instance, avocado juice boosts natural energy in the body; watermelon juice keeps the body hydrated and improves metabolism; papaya juice caters healthy digestion; lemon juice fights viral infections; and pineapple juice reduces cholesterol levels. This, coupled with the refreshing taste and longer shelf-life of fruit juice, makes it one of the most widely consumed beverages across the globe.
Global Fruit Juice Market Drivers:
The consumption of soft drinks, such as colas and flavored sodas, is reducing globally as they have high sugar content, artificial coloring, phosphoric acid, artificial sweeteners, and caffeine which can cause negative effects on the human body. Owing to this, a large number of consumers are shifting from carbonated drinks towards natural fruit juices.
Changing lifestyles and altering eating patterns of the consumers have resulted in an increased intake of affordable, healthy and quick sources of nutrition like packaged fruit juices, thereby catalyzing the growth of the market.
In order to expand the consumer-base, manufacturers are introducing a wide array of flavors, and producing preservative-free and sugar-free fruit juices. In addition to this, growth in the food and beverage industry is boosting the overall demand for fruit juices worldwide.
Earlier, a number of players were hesitant to sell their products in the emerging countries due to the lack of infrastructure and storage facilities. Nonetheless, with a rise in the number of organized retail outlets, several players are now willing to invest in these markets which is expected to bolster the growth of the fruit juice industry.
Breakup by Product Type:
On the basis of type, the global fruit juice market is segregated as 100% fruit juice, nectars, juice drinks, concentrates, powdered juice and others. Currently, juice drinks account for the majority of the market share, representing the most popular product type. Juice drinks contain several vitamins, flavors and anti-oxidants owing to which they are preferred by the consumers.
Breakup by Flavor:
Based on flavors, the market is classified as orange, apple, mango, mixed fruit and others. Amongst these, orange fruit juice holds the majority of the market share as it is rich in vitamin A, vitamin C, calcium and iron.
Breakup by Distribution Channel:
On the basis of distribution channels, supermarkets and hypermarkets represent the largest segment as they offer easy access to a wide variety of fruit juices depending on different brands, types and flavors. Supermarkets and hypermarkets are followed by convenience stores, specialty food stores, online retail and others.
Regional Insights:
On a geographical front, Europe enjoys the leading position in the global fruit juice market. The fast-paced modern lifestyle and high-income levels of the consumers in the region have led to a rise in the demand for on-the-go fruit juices. Europe is followed by North America, Asia Pacific, Latin America, and Middle East and Africa.
Competitive Landscape:
The market is highly fragmented in nature with the presence of several small and large manufacturers who are competing against each other in terms of prices and quality. Some of the leading key players include:
The Coca-Cola Company
Pepsico, Inc.
China Huiyuan Juice Group Limited
WILD Flavors, Inc.
This report provides a deep insight into the global fruit juice industry covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The report also provides a comprehensive analysis for setting up a fruit juice manufacturing plant. The study analyses the processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the fruit juice industry in any manner.
Key Questions Answered in This Report:
- How has the global fruit juice market performed so far and how will it perform in the coming years?
- What are the key regional markets in the global fruit juice market?
- What are the key flavor types segments in the global fruit juice market?
- What are the key product types in the global fruit juice market?
- What are the major distribution channels in the global fruit juice market?
- What are the various stages in the value chain of the global fruit juice market?
- What are the key driving factors and challenges in the global fruit juice market?
- What is the structure of the global fruit juice market and who are the key players?
- What is the degree of competition in the global fruit juice market?
- What are the profit margins in the global fruit juice market?
- What are the key requirements for setting up a fruit juice manufacturing plant?
- How is orange juice manufactured?
- What are the various unit operations involved in a fruit juice manufacturing plant?
- What is the total size of land required for setting up a fruit juice manufacturing plant?
- What are the machinery requirements for setting up a fruit juice manufacturing plant?
- What are the raw material requirements for setting up a fruit juice manufacturing plant?
- What are the packaging requirements for fruit juice?
- What are the transportation requirements for fruit juice?
- What are the utility requirements for setting up a fruit juice manufacturing plant?
- What are the manpower requirements for setting up a fruit juice manufacturing plant?
- What are the infrastructure costs for setting up a fruit juice manufacturing plant?
- What are the capital costs for setting up a fruit juice manufacturing plant?
- What are the operating costs for setting up a fruit juice manufacturing plant?
- What will be the income and expenditures for a fruit juice manufacturing plant?
- What is the time required to break-even?
| 1. Preface 2. Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3. Executive Summary 4. Introduction 4.1 Overview 4.2 Key Industry Trends 5. Global Fruit Juice Industry 5.1 Market Overview 5.2 Market Performance 5.2.1 Volume Trends 5.2.2 Value Trends 5.3 Price Analysis 5.3.1 Key Price Indicators 5.3.2 Price Structure 5.3.3 Margin Analysis 5.4 Market Breakup by Region 5.5 Market Breakup by Type 5.6 Market Breakup by Flavour 5.7 Market Breakup by Distribution Channel 5.8 Market Forecast 5.9 SWOT Analysis 5.9.1 Overview 5.9.2 Strengths 5.9.3 Weaknesses 5.9.4 Opportunities 5.9.5 Threats 5.10 Value Chain Analysis 5.10.1 Input Suppliers 5.10.2 Farmers 5.10.3 Collectors 5.10.4 Processors 5.10.5 Distributiors 5.10.6 Exporters 5.10.7 Retailers 5.10.8 End-Consumers 5.11 Porter’s Five Forces Analysis 5.11.1 Overview 5.11.2 Bargaining Power of Buyers 5.11.3 Bargaining Power of Suppliers 5.11.4 Degree of Competition 5.11.5 Threat of New Entrants 5.11.6 Threat of Substitutes 5.12 Key Success and Risk Factors for Fruit Juice Manufacturers 6. Performance of Key Regions 6.1 Europe 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 North America 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Asia Pacific 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Latin America 6.4.1 Market Trends 6.4.2 Market Forecast 6.5 Middle East and Africa 6.5.1 Market Trends 6.5.2 Market Forecast 7. Market by Type 7.1 100% Fruit Juice 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Nectars 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Juice Drinks 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Concentrates 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Powdered Juice 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Others 7.6.1 Market Trends 7.6.2 Market Forecast 8. Market by Flavour 8.1 Orange 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Apple 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Mango 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Mixed Fruit 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9. Market by Distribution Channel 9.1 Supermarkets and Hypermarkets 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Convenience Stores 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Specialty Food Stores 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Online Retail 9.4.1 Market Trends 9.4.2 Market Forecast 9.5 Others 9.5.1 Market Trends 9.5.2 Market Forecast 10. Competitive Landscape 10.1 Market Structure 10.2 Market Breakup by Key Players 11. Fruit Juice (Orange Juice) Manufacturing Process 11.1 Product Overview 11.2 Detailed Process Flow 11.3 Various Types of Unit Operations Involved 11.4 Mass Balance and Raw Material Requirements 12. Project Details, Requirements and Costs Involved 12.1 Land Requirements and Expenditures 12.2 Construction Requirements and Expenditures 12.3 Plant Machinery 12.4 Machinery Pictures 12.5 Raw Material Requirements and Expenditures 12.6 Raw Material and Final Product Pictures 12.7 Packaging Requirements and Expenditures 12.8 Transportation Requirements and Expenditures 12.9 Utility Requirements and Expenditures 12.10 Manpower Requirements and Expenditures 12.11 Other Capital Investments 13. Loans and Financial Assistance 14. Project Economics 14.1 Capital Cost of the Project 14.2 Techno-Economic Parameters 14.3 Product Pricing and Margins Across Various Levels of the Supply Chain 14.4 Taxation and Depreciation 14.5 Income Projections 14.6 Expenditure Projections 14.7 Financial Analysis 14.8 Profit Analysis 15. Key Player Profiles |
Market by Type
- 100% Fruit Juice
- Nectars
- Juice Drinks
- Concentrates
- Powdered Juice
- Others
Market by Flavour
- Orange
- Apple
- Mango
- Mixed Fruit
- Others
Market by Distribution Channel
- Supermarkets and Hypermarkets
- Convenience Stores
- Specialty Food Stores
- Online Retail
- Others
Bone Cancer Treatment Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 120 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 120 pages
- Published: 07-06-2019
Market Overview
The global bone cancer treatment market was valued at USD 62,865.6 million in 2018, and it is estimated to be valued at USD 83,770.9 million in 2024 while witnessing a CAGR of 4.93%. Certain factors that are driving the market growth include increasing incidence of bone cancer and increasing government initiatives for bone cancer awareness. The incidences of bone cancer are on a steady rise and need to be wisely addressed at the earliest, in order to reduce the burden of bone sarcoma across the world.
According to the estimates by the American Society of Clinical Oncology, the United States was expected to witness 3,450 new cases of bone cancer and an expected 1,590 deaths due to bone cancer in 2018. Moreover, it is important to assure timely diagnosis and treatment, in order to increase the survival rate. Many government organizations are taking initiatives to increase awareness of bone cancer. For instance, the UK Government formed an organization named Genomics England, post the launch of the 100,000 Genomes Project in 2012. Genomic England is responsible for sequencing 100,000 genomes from 700,000 genomes of NHS-registered patients.
However, the chemotherapeutic drugs approved for the treatment of bone cancer do not have an effective treatment regime, as it always varies according to the prevailing conditions, and the way the patient’s body responds to the drug. The associated side effects, risks, and limitations of the treatment are limiting the growth of the global bone cancer treatment drugs market.
Scope of the Report
Bone cancer refers to a malignant tumor that arises from cells of bones of the body. It is also known as primary bone cancer, as it originates in the bones. Secondary bone cancer refers to a tumor that has spread to the bone area but originated elsewhere. In this report, a detailed analysis of the bone cancer treatment market is presented, with specific attention on primary bone cancer.
Key Market Trends
Osteosarcoma is Expected to Hold the Largest Market Share in the Primary Bone Cancer Type
In the bone cancer type segment of the bone cancer treatment market, among all primary bone cancers, osteosarcoma is expected to have largest market size and is likely to witness a CAGR of 6.31% over the forecast period. Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. Based on the cells, osteosarcoma is classified as high-, intermediate- and low-grade. According to the American Cancer Society, about 800 to 900 new cases of osteosarcoma are diagnosed in the United States every year, with about half of these occurring in children and teenagers.
Research on osteosarcoma is done at various medical centers, university hospitals, and other institutions across the world. Many advancements have taken place in the treatment of osteosarcoma in the past few decades. Osteosarcoma can be treated by surgery, radiation therapy, chemotherapy, targeted therapy drugs, etc. Thus, research related to the bone cancer treatment market is increasing, owing to the high prevalence of osteosarcoma, globally.
North America Dominates the Market and is Expected to do Same in the Forecast Period
North America currently dominates the bone cancer treatment market, and it is expected to continue its stronghold for a few more years. This region is expected to increase its market share in the future, owing to the fact that, currently, in the region, mainly in the United States, many clinical trials are underway for bone cancer therapies. Some studies are testing new chemo drugs. Researchers are also looking for new ways to use the existing approved drug portfolio. For instance, doctors are studying whether adding a bisphosphonate called zoledronic acid (Zometa) to the bone cement, which is used in filling the space left after removing a giant cell tumor, may decrease the chances of that tumor returning in that place.
Competitive Landscape
The global bone cancer treatment market is highly competitive and consists of a considerable number of significant players. All of the existing players in global bone cancer treatment market are either legacy suppliers of treatment options, like chemotherapy and radiation therapy, or are concentrating on clinical trials for novel bone cancer approaches, including targeted therapy and immunotherapy. Companies, like Bayer AG, Amgen, Novartis AG, and Pfizer Inc., among others, are expected to hold the substantial market share in the bone cancer treatment market.
Various developments have recently been taking place in the market. For example, in September 2016, Dr. Reddy’s Laboratories (DRL) expanded strategic collaboration with Amgen to market and distribute Xgeva (denosumab), Vectibix (panitumumab), and Prolia (denosumab) in India.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of Bone Cancer
4.2.2 Increasing Government Initiatives for Bone Cancer Awareness
4.3 Market Restraints
4.3.1 Unavailability of Effective Treatment and Side Effects
4.3.2 High Cost of Cancer Therapies
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 Bone Cancer Type
5.1.1 Primary Bone Cancer
5.1.1.1 Osteosarcoma
5.1.1.2 Chondrosarcoma
5.1.1.3 Ewing Tumour
5.1.1.4 Others
5.1.2 Secondary Bone Cancer (Metastatic Bone Cancer)
5.2 Treatment Type
5.2.1 Chemotherapy
5.2.1.1 Doxorubicin
5.2.1.2 Cisplatin
5.2.1.3 Cyclophosphamide
5.2.1.4 Etoposide
5.2.1.5 Other Chemotherapies
5.2.2 Targeted Therapy
5.2.2.1 Denosumab
5.2.2.2 Imatinib
5.2.3 Radiation Therapy
5.2.4 Surgery
5.2.5 Other Treatments
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Amgen
6.1.2 Baxter
6.1.3 Bayer AG
6.1.4 Hikma Pharmaceuticals
6.1.5 Johnson & Johnson
6.1.6 Novartis AG
6.1.7 Pfizer Inc.
6.1.8 Recordati Group
6.1.9 Takeda Pharmaceutical Company
7. Market Opportunities and Future Trends
Market Segmentation
- Bone Cancer Type
Primary Bone Cancer
Osteosarcoma
Chondrosarcoma
Ewing Tumour
Others
Secondary Bone Cancer (Metastatic Bone Cancer)
Treatment Type
Chemotherapy
Doxorubicin
Cisplatin
Cyclophosphamide
Etoposide
Other Chemotherapies
Targeted Therapy
Denosumab
Imatinib
Radiation Therapy
Surgery
Other Treatments
Geography
North America
United States
Canada
Mexico - Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Whole Exome Sequencing Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 07-06-2019
Market Overview
The key factors propelling the global whole exome sequencing market are the increasing applications in clinical diagnosis, high demand for the diagnosis of rare diseases, increasing R&D in the field of genomics and next-generation sequencing, and increasing demand for personalized medicine.
The increase in acceptance of next-generation sequencing methods for prediction, treatment, and monitoring of diverse chronic diseases, such as cancer, is driving the overall market.
The low cost and high speed associated with whole exome sequencing technology, technological advancements in whole exome sequencing techniques, and global alliances among leading research institutes, are some of the major driving forces for the global whole exome sequencing market.
Scope of the Report
Exome sequencing is a technique for sequencing all of the exome and protein-coding genes in a genome. This technique includes selection of the subset of DNA that encodes proteins or exons, followed by sequencing of the exonic DNA using high-throughput DNA sequencing methods. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases, such as Miller syndrome and Alzheimer’s disease. It also provides a cost-effective screening approach for the diagnosis of genetic disorders, and presents itself as a less resource-intensive alternative to whole genome sequencing in several applications, including drug discovery and development processes.
Key Market Trends
Personalized Medicine Segment by Application is Expected to Grow the Fastest During the Forecast Period
Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, and it has become popular over recent years. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel diagnostic and therapeutic technologies must be developed, which in turn, has resulted in the rapid expansion of the global whole exome sequencing market.
North America holds the Largest Market and is Expected to Follow the Same Trend Over the Forecast Period
North America has the largest regional market, in terms of revenue. The increasing prevalence of genetic and chronic disorders, such as cancer, ageing population, increasing demand for targeted and personalized medicine, and favorable government initiatives, are the primary factors behind the growth of the whole exome sequencing market.
Asia-Pacific is expected to be the fastest-growing market for whole exome sequencing. Regular government funding and large numbers of conferences related to the whole exome sequencing technique are the major driving forces for the Asia-Pacific whole exome sequencing market.
Competitive Landscape
There are key players that have adopted strategies, such as collaborations, partnerships, agreements, and new product launches to gain a competitive advantage in the market. In addition, the high investments made by companies, both new and old, are on R&D facilities in this technology, which are also impacting the growth of the market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Applications in the Clinical Diagnosis and High Demand for the Diagnosis of Rare Diseases
4.2.2 Increasing R&D in the Field of Genomics and Next-generation Sequencing
4.2.3 Increasing Demand for Personalized Medicine
4.3 Market Restraints
4.3.1 High Complexity of Technique and Lack of Skilled Personnel
4.3.2 Legal and Ethical Issues Associated with Whole Exome Sequencing
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Product
5.1.1 Systems
5.1.2 Kits
5.1.2.1 Library Preparation Kits
5.1.2.2 Target Enrichment Kits
5.1.3 Services
5.1.3.1 Sequencing Services
5.1.3.2 Data Analysis (Bioinformatics) Services
5.1.3.3 Other Services
5.2 By Technology
5.2.1 Second-generation Sequencing
5.2.1.1 Sequencing, by Synthesis (SBS)
5.2.1.2 Sequencing, by Hybridization and Ligation (SBL)
5.2.2 Third-generation Sequencing
5.3 By Application
5.3.1 Diagnostics
5.3.2 Drug Discovery and Development
5.3.3 Personalized Medicine
5.3.4 Other Applications (Agriculture, Animal Research, etc.)
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Ambry Genetics Corp.
6.1.3 Beijing Genomics Institute
6.1.4 Bio-Rad Laboratories Inc.
6.1.5 Eurofins Scientific Group
6.1.6 F. Hoffmann-La Roche AG
6.1.7 GENEWIZ Inc.
6.1.8 Illumina Inc.
6.1.9 Macrogen Inc.
6.1.10 Pacific Biosciences of California Inc.
7. Market Opportunities and Future Trends
Market Segmentation
- By Product
Systems
Kits
Library Preparation Kits
Target Enrichment Kits
Services
Sequencing Services
Data Analysis (Bioinformatics) Services
Other Services
By Technology
Second-generation Sequencing
Sequencing, by Synthesis (SBS)
Sequencing, by Hybridization and Ligation (SBL)
Third-generation Sequencing
By Application
Diagnostics
Drug Discovery and Development
Personalized Medicine
Other Applications (Agriculture, Animal Research, etc.)
Geography
North America
United States
Canada
Mexico - Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Apheresis Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The propelling factors for the growth of the apheresis market include the increasing number of diseases, a rise in the demand for blood components and associated safety, technological advancement in the development of new apheresis techniques, and rise in the reimbursement policies and funding for apheresis procedures. Due to the aforementioned factors, the apheresis market is expected to experience a boost during the forecast period.
With the increasing number of surgeries and surgical techniques, advanced treatments have led to global demand for blood and the blood components. The need for blood components is significantly growing and contributing to healthcare spending. Apheresis has also recently witnessed a high demand due to an increased number of patients suffering from various ailments related to blood, kidney, metabolic diseases, and neurological disorders. Therefore, apheresis technology is used to reduce the number of white cells, until other medications can control them. With the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, requiring a minimal hospital stay, the global apheresis market is poised to experience growth during the forecast period.
The use of apheresis in clinically ill patients is increasing day by day, and it has been widely used as the primary therapy or as an adjunct to other treatments for various diseases, such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, drug toxicities, autoimmune disease, sepsis, and fulminant hepatic failure.
Therefore with the steady increase in the number of patients suffering from these diseases, ailments, and the technical ease of using these devices in the treatment of these diseases, thus requiring a minimal hospital stay, the global apheresis market is poised to experience growth during the forecast period.
The Scope of the Report
As per the scope of the report, apheresis is a medical technique where the blood of an individual, be a donor or a patient, is passed through an apparatus that segregates out a particular constituent and returns the rest to the blood circulation. It involves blood purification and blood component separation by using centrifugation or membrane filtration technology. This procedure is performed for blood donation component or for the treatment of disease.
Key Market Trends
Hematological Disorders is the Segment under Application that is Expected to Grow Fastest during the Forecast Period
Hematological disorders are found common in low-income countries, and they make a substantial contribution to morbidity and mortality of individuals in these regions. Hence, owing to the increasing burden of hematological incidences and growing applications of apheresis as a treatment method for hematological disorders, the apheresis market for hematological disorders is expected to experience growth in the forecast period.
The recent years brought about a rise in new options of therapeutic apheresis, such as immunoadsorption, double filtration and cytapheresis used in the treatment of both primary and secondary autoimmune renal diseases. Those methods, more selective and safer than the classic TA, are potentially more efficient in the removal of pathogens, thus reducing the intoxication of the patient’s organism.
Asia-Pacific holds the Fastest Growth and is Expected to follow the Same Trend over the Forecast Period
The Asia-Pacific region is predicted to witness high growth, owing to the rising geriatric population and the increasing prevalence of several choric diseases. China is found to be one of the largest consumers and manufacturers in the global plasma-derived products market and serves a vast population. Great progress has been made in the Chinese plasma fractionation industry in the past 50 years. Moreover, increasing healthcare expenditure is another critical factor that is likely to enhance the growth of the market in the near future.
Competitive Landscape
The market studied is dominated by a few major players, and currently, the market is well established in many areas and has shown nascent success history. However, its full potential is yet to be determined in the developing regions. With increasing government initiatives, there is an awareness among people, which is further driving the growth of the market studied.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Global Disease Burden
4.2.2 Rise in Demand for Blood Components and Associated Safety
4.2.3 Technological Advancement in Development of New Apheresis Techniques
4.2.4 Rise in the Reimbursement Policies and Funding for Apheresis Procedures
4.3 Market Restraints
4.3.1 High Capital Investment and Costs Associated with Apheresis Procedures
4.3.2 Lack of Qualified Skilled Professionals
4.3.3 Risk of Blood Contamination
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Product
5.1.1 Devices
5.1.2 Disposables
5.1.2.1 Interventional/Surgical Simulators
5.2 By Apheresis Procedure
5.2.1 Leukapheresis
5.2.2 Plasmapheresis
5.2.3 Plateletpheresis
5.2.4 Erythrocytapheresis
5.2.5 Other Apheresis Procedures
5.3 By Technology
5.3.1 Centrifugation
5.3.2 Membrane Separation
5.4 By Application
5.4.1 Renal Disorders
5.4.2 Hematological Disorders
5.4.3 Neurological Disorders
5.4.4 Autoimmune Disorders
5.4.5 Other Applications
5.5 Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 Europe
5.5.2.1 Germany
5.5.2.2 United Kingdom
5.5.2.3 France
5.5.2.4 Italy
5.5.2.5 Spain
5.5.2.6 Rest of Europe
5.5.3 Asia-Pacific
5.5.3.1 China
5.5.3.2 Japan
5.5.3.3 India
5.5.3.4 Australia
5.5.3.5 South Korea
5.5.3.6 Rest of Asia-Pacific
5.5.4 Middle East & Africa
5.5.4.1 GCC
5.5.4.2 South Africa
5.5.4.3 Rest of Middle East & Africa
5.5.5 South America
5.5.5.1 Brazil
5.5.5.2 Argentina
5.5.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Asahi Kasei Corporation
6.1.2 B. Braun Melsungen AG
6.1.3 Cerus Corporation
6.1.4 Fresenius SE & Co. KGaA
6.1.5 Haemonetics Corporation
6.1.6 HemaCare Corporation
6.1.7 Kaneka Corporation
6.1.8 Kawasumi Laboratories Inc.
6.1.9 Terumo Corporation
6.1.10 Therakos Inc.
7. Market Opportunities and Future Trends
Market Segmentation
- By Product
Devices
Disposables
Interventional/Surgical Simulators
By Apheresis Procedure
Leukapheresis
Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Other Apheresis Procedures
By Technology
Centrifugation
Membrane Separation
By Application
Renal Disorders
Hematological Disorders
Neurological Disorders
Autoimmune Disorders
Other Applications
Geography
North America
United States
Canada
Mexico - Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Defibrillator Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 07-06-2019
Market Overview
The growth of the defibrillator market can be attributed to factors such as technological advancements in the field of defibrillators and training and awareness programs for defibrillators. According to the American Heart Association’s research program, cardiovascular diseases are listed as the primary cause of deaths, and accounted for nearly 836,546 deaths in the United States. The deaths related to cardiovascular diseases are higher when compared to deaths related to all forms of cancer and chronic lower respiratory diseases combined. As per the American Heart Association, cardiovascular disease is the leading cause of death, globally, accounting for more than 17.9 million deaths per year in 2015, a number that is expected to grow to more than 23.6 million by 2030. Hence, the increase in prevalence of cardiovascular diseases is expected to drive the market growth.
Scope of the Report
Defibrillator is a life-saving device that helps deliver a therapeutic shock to a patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. In the United States, approximately 300,000 out-of-hospital cardiac arrests occur each year. Supportive government policies in developed countries may help increase the availability and access of defibrillators, which will likely further boost the market growth over the forecast period.
Key Market Trends
Implantable Cardioverter Defibrillator(ICD) Spearheaded the Defibrillator Market
The implantable cardioverter defibrillator (ICD) segment accounted for the largest share in the global market. The ICDs are of three major types, namely transvenous ICDs, subcutaneous ICDs, and CRT with pacemaker and ICD function. The transvenous and subcutaneos ICDs are expected to exhibit the fastest growth rate over the forecast period, owing to the rising technological advancements, increasing R&D, and benefits associated with these ICDs. The overall ICD segment contributes for the largest market share, owing to the rising integration of multiple technological capabilities in a single device, such as defibrillators and pacemakers. In addition, the efficacy of these devices to manage arhythmias for a prolonged period is expected to drive the segment growth over the forecast period.
North America Dominated the Global Defibrillator Market
Cardiovascular diseases, listed as the underlying cause of death, account for nearly 836,546 deaths (about 1 of every 3 deaths) in the United States. Thus, the increasing prevalence of cardiovascular diseases in the region is expected to drive the growth of this market over the forecast period. In 2017, the Department of Health and Human Services (HHS), along with a number of public and private partners, launched the Million Hearts initiative that aims to prevent one million heart attacks and strokes. All the aforementioned factors are expected to boost the market growth.
Competitive Landscape
The major players operating in the defibrillators market are Boston Scientific Corporation, Koninklijke Philips NV., Medtronic, Nihon Kohden Corporation, and Abbott Laboratories. The key strategies adopted by the major market players are acquisitions and mergers, new product developments, geographical expansions, and enhanced marketing strategies.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Cardiovascular Diseases
4.2.2 Technological Advancements in the Field of Defibrillators
4.2.3 Training and Awareness Programs about Defibrillators
4.3 Market Restraints
4.3.1 High Costs of Defibrilators
4.3.2 Stringent Regulatory Framework
4.4 Industry Attractiveness Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Product
5.1.1 Implantable Cardioverter Defibrillator
5.1.1.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
5.1.1.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
5.1.1.3 CRT with Pacemaker and ICD Function (CRT-D)
5.1.2 External Defibrillator (ED)
5.1.2.1 Automated External Defibrillator (AEDs)
5.1.2.1.1 Semi-automated External Defibrillators
5.1.2.1.2 Fully-automated External Defibrillators
5.1.2.2 Manual External Defibrillator
5.1.2.3 Wearable Cardioverter Defibrillators (WCDs)
5.2 By End User
5.2.1 Hospitals
5.2.2 Emergency Care
5.2.3 Home Care
5.2.4 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 United Kingdom
5.3.2.2 Germany
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Boston Scientific Corporation
6.1.3 Cardiac Science Corporation
6.1.4 Defibtech LLC
6.1.5 Koninklijke Philips NV
6.1.6 LivaNova PLC
6.1.7 Medtronic plc.
6.1.8 NIHON KOHDEN CORPORATION
6.1.9 Physio-Control Inc.
6.1.10 ZOLL Medical Corporation
7. Market Opportunities and Future Trends
Market Segmentation
- By Product
Implantable Cardioverter Defibrillator
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
CRT with Pacemaker and ICD Function (CRT-D)
External Defibrillator (ED)
Automated External Defibrillator (AEDs)
Semi-automated External Defibrillators
Fully-automated External Defibrillators
Manual External Defibrillator
Wearable Cardioverter Defibrillators (WCDs)
By End User
Hospitals
Emergency Care
Home Care
Other End Users
Geography
North America
United States
Canada
Mexico - Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America